NewsMarketsNew Investment For Cannabis Europa Firm.

New Investment For Cannabis Europa Firm.

-

THE owners of a popular annual London cannabis event have secured new investment.

NOBL, a UK cannabis data, conferences and consulting firm, recently closed a Series A funding of €1.48m.

Investors included the New York firm Altitude Investment Management (AIM), Artemis Growth Partners and Enexis AB.

Spun out last year from European Cannabis Holdings NOBL’s brands include, Prohibition Partners, NOBL Live, Atalis, Cannabis Europa and European Cannabis Week. 

Stephen Murphy, Founder and CEO of NOBL, said: “We will continue to invest in talent and innovation while also enabling our operating companies to make smarter and more effective business decisions that will shape the future of the global cannabis industry in a meaningful and impactful way.”

The NOBL deal marks the latest foray into the European cannabis industry for AIM following the opening of a London base last year. 

2019 also saw a $5.5m investment into Swiss-based KannaSwiss – a supplier of CBD isolates.

The partners say the cash will be used to develop its medical cannabis division, scale-up its extraction operations in both CBD isolate and distillate, and boost marketing and sales.  

AIM has been an active investor in North America, with stakes in many industry leading lights including; The Green Organic Dutchman, BDS Analytics and Canndescent.

One of its first European investments was into Spanish company Emmac Life Sciences.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities - not...

IM Cannabis Clinical Survey Confirms Effectiveness of Proprietary Strains in Alleviating Symptoms of Seven Key Health Conditions

IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ:IMCC, CSE:IMCC), a multi-country operator ("MCO") in the medical and adult-use recreational...

Always Pure Organics Makes £3m Continental Swoop For Leading B2C Hemp And CBD Player

FAST-GROWING UK cannabis wholesaler Always Pure Organics has acquired two Belgian companies - Distribution Legal Hemp and NexGen -...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former Canopy Growth medicinal cannabis cultivation and manufacturing facility in Denmark...

New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane

THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000...

How Britain’s Three Crown Dependencies Are Stealing A Cannabis March On the Mainland

FRUSTRATED by the UK Government’s stance the three UK Crown Dependencies of Jersey, Guernsey and the Isle of Man,...

Must read

Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals

THE initial warm welcome to proposals to make UK...

Little Green Pharma Picks Up Distressed Canadian LP’s Danish Cannabis Asset for £11.6m

AUSTRALIAN company Little Green Pharma has purchased the former...

You might also likeRELATED
Recommended to you